Aurobindo Pharma Q2 net profit rises 8.6% to Rs 817 crore in Q2FY25 0 10.11.2024 06:36 Economictimes.indiatimes.com Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in Europe and growth markets. Despite a dip in US formulations revenue, the company's overall revenue rose by 8% YoY. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
